Leucid Bio
Chemicals & Related Products · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Wing Guy's Hospital Bermondsey Fl 3, Lon...Website
www.leucid.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Leucid Bio
Leucid Bio, based in London, United Kingdom, is a pioneering cell therapy company with a pipeline of novel cell therapies developed using its proprietary engine. Leucid's focus is on the development of chimeric antigen receptor T cell (CAR T) therapies for patients with solid tumors and no treatment options.Explore more
Leucid Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leucid Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Leucid Bio has new funding data
Website visits: Recent activity has been detected on your website
Leucid Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Leucid Bio
Check if Leucid Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Leucid Bio recently announced quarterly report
Check out if Leucid Bio is spiking on competitors!
Click to see if Leucid Bio had a recent Job posting/layoffs
Product Launch: Get notified when Leucid Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Leucid Bio
Find more new buyers
Compare Similar Companies to Leucid Bio
Compare insights from companies similar to Leucid Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Leucid Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Leucid Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leucid Bio.
Leucid Bio financials insights
Gather financial insights about Leucid Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$16M
Leucid Bio Tech Stack
A closer look at the technologies used by Leucid Bio
Leucid Bio News & Media
Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours
Proof-of-concept established for LEU011 in the treatment of relapsed/refractory solid tumours LEU011 has been well tolerated, with disease control observed in multiple patients at lowest dose evaluated to date Enrolment continues in dose-escalation segment of the AERIAL trial with...Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
LONDON, Aug. 28, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using the Company's proprietary lateral CAR platform, today announced that it will...Leucid Bio Announces Treatment of First Patient in AERIAL Trial of NKG2D CAR-T Therapy LEU011 for Solid Tumours
Initiation of AERIAL trial accelerated by successful first close of Series A1 financing LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured at Great Ormond Street Hospital (GOSH) Enrolment continues in AERIAL trial with initial data for LEU011 expected in...Leucid Bio to Participate in Upcoming Healthcare Conferences
LONDON, Oct. 31, 2023 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using the Company's proprietary Lateral CAR platform, today announced that...
Read more news
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leucid Bio
Sign Up For FreeTo access detailed company insights
Leucid Bio, based in London, United Kingdom, is a pioneering cell therapy company with a pipeline of novel cell therapies developed using its proprietary engine. Leucid's focus is on the development of chimeric antigen receptor T cell (CAR T) therapies for patients with solid tumors and no treatment options.... Read More
